{
    "symbol": "PRVA",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-14 13:36:02",
    "content": " Your line is now open. Your line is now open. Your line is now open. Your line is now open. So on practice collections, like I mentioned, it's fairly broad-based beat across both utilization on the fee-for-service, good performance on value-based care, and then provider ads were pretty strong ending last year. Your line is now open. And I think you're getting this business given our guidance that is now growing 35% this year on the top line and 35% plus on EBITDA, and we're not sacrificing that \u2013 any compression from those investments, it speaks to the scale of the business already and where we are with our margin profile, pretty much halfway there, or more than halfway there from a long-term margin. Your line is now open. Your line is now open. Your line is now open. As we get dense and build density in a certain geography, the \u2013 you'd say there's five to six specialties that you really want to \u2013 you want to, I guess, get the right volume to the right providers, think about sites of service and ambulatory surgery, all those type of things that are the levers of just traditional \u2013 any kind of traditional managed care. We \u2013 maybe it's primary care risk initially, but then we're moving upstream to professional and then 50-50 and really starting to kind of think about how we impact that institutional pool. Your line is now open. But it does \u2013 it's reflecting on kind of, I think, our growth where physicians are \u2013 they're seeing pressures that they probably haven't seen in the last few years. Your line is now open. Your line is now open."
}